journal article·2021-01

Heavy‐Atom‐Modulated Supramolecular Assembly Increases Antitumor Potency against Malignant Breast Tumors via Tunable Cooperativity

Zhengqing Guo, Hui He, Yi Zhang, Jiaming Rao, Tao Yang, Ting Li, Lu Wang, Mengke Shi, Mengya Wang, Shihong Qiu, Xue Song, Hengte Ke, Huabing Chen

Advanced Materials· Volume 33· Issue 2
Publisher page

Abstract

Abstract Triple‐negative breast cancer (TNBC) remains with highest incidence and mortality rates among females, and a critical bottleneck lies in rationally establishing potent therapeutics against TNBC. Here, the self‐assembled micellar nanoarchitecture of heavy‐atom‐modulated supramolecules with efficient cytoplasmic translocation and tunable photoconversion is shown, for potent suppression against primary, metastatic, and recurrent TNBC. Multi‐iodinated boron dipyrromethene micelles yield tunable photoconversion into singlet oxygen and a thermal effect, together with deep penetration and subsequent cytoplasmic translocation at the tumor. Tetra‐iodinated boron dipyrromethene micelles (4‐IBMs) particularly show a distinctly enhanced cooperativity of antitumor efficiency through considerable expressions of apoptotic proteins, potently suppressing subcutaneous, and orthotopic TNBC models, together with reduced oxygen dependence. Furthermore, 4‐IBMs yield preferable anti‐metastatic and anti‐recurrent efficacies through the inhibition of metastasis‐relevant proteins, distinct immunogenic cell death, and re‐education of M2 macrophages into tumoricidal M1 phenotype as compared to chemotherapy and surgical resection. These results offer insights into the cooperativity of supramolecular nanoarchitectures for potent phototherapy against TNBC.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Photodynamic Therapy Research Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Radiation Medicine and Protection Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, and School of Radiation Medicine and Protection Soochow University Suzhou 215123 China

Jiangsu Key Laboratory of Neuropsychiatric Diseases College of Pharmaceutical Sciences Soochow University Suzhou 215123 China

Funding

National Basic Research Program of China · National Natural Science Foundation of China · Priority Academic Program Development of Jiangsu Higher Education Institutions

References (59)

Show source-provided references
1. 10.3322/caac.2149210.3322/caac.21492 ↗
2. 10.3322/caac.2155110.3322/caac.21551 ↗
3. 10.1007/s13346-018-0551-310.1007/s13346-018-0551-3 ↗
4. 10.1056/NEJMoa180961510.1056/NEJMoa1809615 ↗
5. 10.1126/sciimmunol.aau658410.1126/sciimmunol.aau6584 ↗
6. 10.1186/s13046-019-1443-110.1186/s13046-019-1443-1 ↗
7. 10.1038/nchembio.229710.1038/nchembio.2297 ↗
8. 10.1038/s41565-019-0567-y10.1038/s41565-019-0567-y ↗
9. 10.1126/scitranslmed.aaf684310.1126/scitranslmed.aaf6843 ↗
10. 10.1021/cr400532z10.1021/cr400532z ↗
11. 10.1021/acs.chemrev.8b0062610.1021/acs.chemrev.8b00626 ↗
12. 10.1039/C7CS00594F10.1039/C7CS00594F ↗
13. 10.1080/17425247.2016.120865010.1080/17425247.2016.1208650 ↗
14. 10.1038/nbt.333010.1038/nbt.3330 ↗
15. 10.1038/s41467-018-06574-710.1038/s41467-018-06574-7 ↗
16. 10.1016/j.ccr.2017.09.02910.1016/j.ccr.2017.09.029 ↗
17. 10.1002/adma.20160273810.1002/adma.201602738 ↗
18. 10.1002/anie.20181473010.1002/anie.201814730 ↗
19. 10.1002/smll.20180492710.1002/smll.201804927 ↗
20. 10.1038/s41571-020-0410-210.1038/s41571-020-0410-2 ↗
21. 10.1021/jacs.9b1180010.1021/jacs.9b11800 ↗
22. 10.1002/adhm.20200104210.1002/adhm.202001042 ↗
23. 10.1007/s11426-018-9397-510.1007/s11426-018-9397-5 ↗
24. 10.1039/C7BM01210A10.1039/C7BM01210A ↗
25. 10.1016/j.biopha.2018.07.04910.1016/j.biopha.2018.07.049 ↗
26. 10.1021/acs.chemrev.8b0019910.1021/acs.chemrev.8b00199 ↗
27. 10.1021/acs.chemrev.8b0019510.1021/acs.chemrev.8b00195 ↗
28. 10.1039/C6CS00898D10.1039/C6CS00898D ↗
29. 10.1039/C7CS00391A10.1039/C7CS00391A ↗
30. 10.7150/thno.3165310.7150/thno.31653 ↗
31. 10.1039/C9CS00622B10.1039/C9CS00622B ↗
32. 10.1039/D0TB00609B10.1039/D0TB00609B ↗
33. 10.1002/adma.20200266110.1002/adma.202002661 ↗
34. 10.1038/ncomms1321410.1038/ncomms13214 ↗
35. 10.1038/nmat381910.1038/nmat3819 ↗
36. 10.1038/nnano.2014.20810.1038/nnano.2014.208 ↗
37. 10.1038/nnano.2017.5210.1038/nnano.2017.52 ↗
38. 10.1039/C5CS00364D10.1039/C5CS00364D ↗
39. 10.1039/c8pp00113h10.1039/c8pp00113h ↗
40. 10.1038/nnano.2011.16610.1038/nnano.2011.166 ↗
41. 10.1002/adma.20180121610.1002/adma.201801216 ↗
42. 10.1021/acsnano.7b0423010.1021/acsnano.7b04230 ↗
43. 10.1021/acsnano.5b0284310.1021/acsnano.5b02843 ↗
44. 10.1021/ja406992w10.1021/ja406992w ↗
45. 10.1073/pnas.110112610810.1073/pnas.1101126108 ↗
46. 10.1021/acsnano.6b0129610.1021/acsnano.6b01296 ↗
47. 10.1038/nrc367210.1038/nrc3672 ↗
48. 10.1038/nnano.2015.34210.1038/nnano.2015.342 ↗
49. 10.1038/s41570-018-012010.1038/s41570-018-0120 ↗
50. 10.1038/s41551-016-000610.1038/s41551-016-0006 ↗
51. 10.1038/s41551-017-005710.1038/s41551-017-0057 ↗
52. 10.1038/ncomms683410.1038/ncomms6834 ↗
53. 10.1007/s10555-007-9055-110.1007/s10555-007-9055-1 ↗
54. 10.1002/anie.20190396810.1002/anie.201903968 ↗
55. 10.1038/s41565-019-0373-610.1038/s41565-019-0373-6 ↗
56. 10.3892/ol.2015.296510.3892/ol.2015.2965 ↗
57. 10.1016/j.cancergen.2017.07.00410.1016/j.cancergen.2017.07.004 ↗
58. 10.1002/adma.20180830310.1002/adma.201808303 ↗
59. 10.1021/acs.nanolett.8b0356810.1021/acs.nanolett.8b03568 ↗